Phase 2 Study of Lovastatin as Breast Cancer Chemoprevention

NCT00285857 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
30
Enrollment
OTHER
Sponsor class

Stopped Slow accrual

Conditions

Interventions

Sponsor

Stanford University